MLL gene rearrangement and 5-year EFS
. | CCG 1953 . | . | |
|---|---|---|---|
| MLL/11q23 abnormality . | No. of patients . | 5-year EFS, % . | |
| t(4;11)(q21;q23) | 35 | 29.0 | |
| t(11;19)(q23;p13) | 20 | 30.0 | |
| t(9;11)(p22;q23) | 9 | 22.2 | |
| Other 11q23 | 15 | 53.3 | |
| Nonrearranged | 36 | 60.3 | |
. | CCG 1953 . | . | |
|---|---|---|---|
| MLL/11q23 abnormality . | No. of patients . | 5-year EFS, % . | |
| t(4;11)(q21;q23) | 35 | 29.0 | |
| t(11;19)(q23;p13) | 20 | 30.0 | |
| t(9;11)(p22;q23) | 9 | 22.2 | |
| Other 11q23 | 15 | 53.3 | |
| Nonrearranged | 36 | 60.3 | |
For the CCG 1953 study, N = 115.